Amicus Therapeutics Inc (MEX:FOLD)
MXN 208.8 0 (0%) Market Cap: 61.32 Bil Enterprise Value: 65.27 Bil PE Ratio: 0 PB Ratio: 16.63 GF Score: 79/100

Amicus Therapeutics Inc at Bank of America Healthcare Conference Transcript

May 11, 2022 / 07:00PM GMT
Release Date Price: MXN210
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst

Good afternoon, and welcome to the Bank of America Healthcare Conference. I am Tazeen Ahmad. I'm one of the senior SMID biotech analysts here at the bank. It's my pleasure to have our next presenting company, Amicus Therapeutics, for the next half hour or so. Sitting next to me is President and current COO, but incoming CEO, Brad Campbell. Brad, welcome.

Bradley L. Campbell
Amicus Therapeutics, Inc. - President, COO & Director

Thank you. It's nice to see you in-person for the first time in years.

Questions & Answers

Tazeen Ahmad;Bradley L. Campbell<
BofA Securities, Research Division - MD in Equity Research & Research Analyst

Yes, we're back live after 3 years. So maybe let's just start off with an overview of the company, for those who might not be as familiar. And from there, we can maybe go into some more detailed questions on the many things that are happening at the company.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot